Bill Beckerman

Office hours. Patient: “You look pretty young for a surgeon.” Me: “Thanks, you can’t see my grey hair under my scrub cap.” Pt: “So you’ve done a lot of these surgeries?” Me: “Plenty. Maybe one, two a week.” (Confidently takes a sip of coffee from the mug @DanHan just sent him)

@UMNSurgery @UMNVascularSurg Congratulations!

Welcome to the #UMNSurgery team, and congratulations to our incoming Vascular Surgery resident, Renxi Li, MD! 🎊🥳 #VascularSurgery #VascularMatch

@NMVascSurg @khalilqatoMD @KarenYuan_Med @SeungBaek26 Strong work 💪! @RWJMS and @LoyolaHealth’s finest!

We are thrilled to welcome our new interns Karen Yuan and Seung Woo Baek to our vascular family! 🥳 Congratulations on all of your hard work, we are so excited to have you join the team! #VascSurg #NextGenVascular #Match2026 @KarenYuan_Med @SeungBaek26

@EinsteinVasSurg Congratulations!!

Warm welcome and congratulations to Impreet Singh from SUNY Upstate Medical University who will be our incoming PGY-1 Integrated Vascular Surgery Resident! #Match2026 #Vascularsurgery

Happy #MatchDay! ✉️🎉 Read below for a message from the SVS. #VascSurg #NextGenVascular #MatchWeek #Match2026

@moira_mcgevna @CCFVascSurg @NextGenVascular @RWJMS So proud to see all your hard work paying off!

So excited to share that I’ve matched at the Cleveland Clinic (@CCFVascSurg). Grateful for everyone that has been a part of my journey these last five years. Can’t wait for the next chapter! #Match2026 @NextGenVascular @RWJMS

Thrilled to announce we Matched @DrexelMedicine’s Pooja Balar into our Integrated Vascular Surgery Residency at @RutgersU @RWJMS! Congrats to Pooja and the rest of her future vascular surgeons colleagues in #VascularMatch2026 #VascMatch2026 #Match2026

Are you a medical student planning Vascular Surgery sub-internships? Tune into our upcoming panel to learn all the tips for success!

The Department of Surgery at the Medical College of Georgia is proud to announce ACGME accreditation of our new Integrated Vascular Surgery Residency Program. We are now accepting applications outside The Match for candidates to start July 1, 2026. This program offers comprehensive training in open and endovascular surgery within a collaborative academic medical center committed to surgical excellence, education, and innovation. For application information and inquiries, please contact: VASCULAR_RESIDENCY@augusta.edu More details and application instructions coming soon — stay tuned!

32’F at the start line - but it’s not the Big Warm, it’s the @RutgersU Big Chill 5K, baby! Another great morning with the @RWJMS Division of Vascular Surgery, working hard in and out of the hospital. A great event, supporting RU students and donating toys to local kids in need.

@jaygirimd @farkomd Because the real world isn’t divided into two clear on distinct groups of asymptomatic patients. Very few CAS patients wouldn’t be able to tolerate a CEA done under local and regional anes. And the trial will be interpreted as a comparison even if that wasn’t the intent.

@BillBeckerman @farkomd You keep framing this as a comparative trial when it wasn’t one. It was 2 separate RCTs. We’ve got plenty of data comparing CAS vs CEA directly already: jacc.org/doi/10.1016/j.…

Applause to the authors for an exceptional NEJM study on asymptomatic carotid disease. High-quality data, thoughtful analysis, and meaningful implications for practice. Are stents starting to take the lead? #NEJM #CarotidDisease #SVIN2025

@jaygirimd @farkomd There were 8 vs 9 peri-op adverse events in CAS vs CEA. The results are driven by differences in the control groups and events for CEA at like 3 years with no explanation aside from noise. Again, sorry. To change recommendations based on this study is crazy.

@BillBeckerman @farkomd 1) “underpowered” is based on the event rate difference the trialists found clinically meaningful, ~ 1% per annum benefit of CEA over 4 years. So if you say underpowered, you are saying a smaller per annum stroke rate difference is meaningful.

@jaygirimd @farkomd 3) if you had a common control group, you could’ve enrolled 33% more patients in each intervention group without increasing the number of patients enrolled in the trial. CREST-2 is as flawed as CREST-1 was. And this is coming from an early adopter of TCAR.

@farkomd @BillBeckerman Disagree with above critiques: 1) “fragility” of events is an artificial argument as power and planned p value threshold already reflect this. 2) control event rates differ bc CEA pts lower stroke risk- this prob reflects real world practice. Does not affect internal validity

@farkomd Can’t argue with the effort, I know it was an undertaking.

@BillBeckerman You would applaud the effort of the authors though. That’s a lot of work

Grateful to present our research at @VascularEVS from my time at @nyu_vascsurgery on robotic first rib resection for thoracic outlet syndrome. Grateful for the mentorship and support that made this work possible! @KatherineTeter @CaronRockman @VascularSVS @VascularOnline #EVS2025

@farkomd Not sure I’ve ever achieved a 94. Good to have goals to aspire to.

Not a terrible night of call. The running was 800 repeats. No SMA clots in the deer

Should be a good discussion tomorrow about shepherding your research from idea to publication. Register via the link below!

Can’t wait to join everyone at @EndovascularNY in a couple short months. Discussion of aortic cases is second to none. (And the prizes aren’t bad either). Would highly recommend vascular trainees reserve a spot and secure a scholarship ASAP! @FutureVascSurgn @VessVsig